Pluripotent and Somatic Stem Cells: From Basic Science to Utilization in Disease Modeling and Therapeutic Application

Abstract

Get full access to this article

View all access options for this article.

References

Amit

, Chebath

, Margulets

et al. 2010. Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells. Stem Cell Rev., 6:248–259.

Amit

, Laevsky

, Miropolsky

et al. 2011. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat. Protoc., 6:572–579.

Amps

, Andrews

P.W.

, Anyfantis

et al. 2011. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol., 29:1132–1144.

Bellin

, Marchetto

M.C.

, Gage

F.H.

et al. 2012. Induced pluripotent stem cells: The new patient? Nat. Rev. Mol. Cell Biol., 13:713–726.

Cirak

, Arechavala-Gomeza

, Guglieri

et al. 2011. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet, 378:595–605.

Davis

R.P.

, Casini

, van den Berg

C.W.

et al. 2012. Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation, 125:3079–3091.

Fleischmann

, Horn

P.A.

2009 Pluripotency and reprogramming: meeting report on the Fifth International Meeting of the Stem Cell Network North Rhine Westphalia. Cloning Stem Cells, 11:473–475.

Gifford

C.A.

, Ziller

M.J.

, Gu

et al. 2013. Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell, 153:1149–1163.

Gramlich

, Michely

, Krohne

et al. 2009. Stress-induced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based disease. J. Mol. Cell. Cardiol., 47:352–358.

10.

Gurdon

J.B.

, Laskey

R.A.

, Reeves

O.R.

1975. The developmental capacity of nuclei transplanted from keratinized skin cells of adult frogs. J. Embryol. Exp. Morphol., 34:93–112.

11.

Herman

D.S.

, Lam

, Taylor

M.R.

et al. 2012. Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med., 366:619–628.

12.

Hyka-Nouspikel

, Desmarais

, Gokhale

P.J.

et al. 2012. Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cells. Stem Cells, 30:1901–1910.

13.

Kitao

, Takata

2011. Fanconi anemia: A disorder defective in the DNA damage response. Int. J. Hematol., 93:417–424.

14.

Knoepfler

P.S.

2009. Deconstructing stem cell tumorigenicity: A roadmap to safe regenerative medicine. Stem Cells, 27:1050–1056.

15.

Lahti

A.L.

, Kujala

V.J.

, Chapman

et al. 2012. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis. Models Mech., 5:220–230.

16.

Mak

A.N.

, Bradley

, Bogdanove

A.J.

et al. 2013. TAL effectors: Function, structure, engineering and applications. Curr. Opin. Struct. Biol., 23:93–99.

17.

Muller

L.U.

, Milsom

M.D.

, Harris

C.E.

et al. 2012. Overcoming reprogramming resistance of Fanconi anemia cells. Blood, 119:5449–5457.

18.

Radtke

, Horn

P.A.

2011 Cells, niche, fate: Meeting report on the 6th International Meeting of the Stem Cell Network North Rhine Westphalia. Cell. Reprogram, 13:381–384.

19.

Raya

, Rodriguez-Piza

, Guenechea

et al. 2009. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature, 460:53–59.

20.

Soulier

2011. Fanconi anemia. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Educ. Progr., 2011:492–497.

21.

Takahashi

, Yamanaka

2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.

22.

Takahashi

, Tanabe

, Ohnuki

et al. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.

23.

Trobridge

G.D.

, Horn

P.A.

, Beard

B.C.

et al. 2012. Large animal models for foamy virus vector gene therapy. Viruses, 4:3572–3588.

24.

van Deutekom

J.C.

, Janson

A.A.

, Ginjaar

I.B.

et al. 2007. Local dystrophin restoration with antisense oligonucleotide PRO051. N. Engl. J. Med., 357:2677–2686.

25.

Vierbuchen

, Wernig

2012. Molecular roadblocks for cellular reprogramming. Mol. Cell, 47:827–838.

26.

Vierbuchen

, Ostermeier

, Pang

Z.P.

et al. 2010. Direct conversion of fibroblasts to functional neurons by defined factors. Nature, 463:1035–1041.

27.

Villard

, Perret

, Gary

et al. 2011. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur. Heart J., 32:1065–1076.

28.

Wagner

J.E.

, Eapen

, MacMillan

M.L.

et al. 2007. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood, 109:2256–2262.

29.

Wurm

, Horn

P.A.

2008 Reprogramming, regeneration, and the stem cell niche: meeting report on the 4th International Meeting of the Stem Cell Network North Rhine Westphalia. Cloning Stem Cells, 10:183–188.

30.

Zhu

, Adli

, Zou

J.Y.

et al. 2013. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell, 152:642–654.